Potential dietary feed additives with antibacterial effects and their impact on performance of weaned piglets: A meta-analysis.

This meta-analysis evaluated the use of potential dietary feed additives (pDFA) with antibacterial effects and their impact on the perfomance of weaned piglets. Twenty-three peer-reviewed in vivo studies, comprising 50 trials, were identified between January 2010 and January 2017. The pDFA in these studies could be grouped in 5 classes: antimicrobial peptides, chitosan, lysozyme, medium chain fatty acids/ triglycerides and plant extracts. Mixed-effect meta-analyses with type of pDFA as fixed effect were performed for the growth parameters 'average daily gain' (ADG) and 'feed conversion ratio' (FCR), which are the two most important and used economic performance parameters for farmers. For each class of pDFA, results of the meta-analysis showed significantly higher average daily gain in the group with pDFA compared to the negative control group, while no significant difference with the positive control group was observed. Furthermore, a positive effect on FCR was found, i.e. significantly less feed was needed to gain 1 kg of body weight in the group with pDFA compared to the negative control group. No significant differences with positive control groups were observed for each class of pDFA, except for plant extracts, where the FCR was also significantly reduced in the treatment group. These results suggest that pDFA could reduce the use of antimicrobials without significant negative effects on performance indicators.

Effect of coated and non-coated fatty acid supplementation on broiler chickens experimentally infected with Campylobacter jejuni.

The aim of this study was to examine whether and to what extent the supplementation of feed with a coated or non-coated mixture of fatty acids (caprylic and capric acid) affects broiler chickens experimentally infected with Campylobacter jejuni. The study was carried out using 48 chickens divided into four experimental groups. Throughout the whole rearing period (1-42 days), the chickens were fed a diet supplemented with 0.25% caprylic and capric acid (1:1), coated or non-coated. At the age of 14 and 28 days, chickens were orally challenged with C. jejuni. At regular time intervals post-inoculation, the shedding of C. jejuni was assayed using quantitative real-time PCR. Both supplements significantly decreased faecal C. jejuni counts by 1.2-4.1 log(10) CFU/g 4 days post-inoculation; after this time period, the effect of medium-chain fatty acids (MCFA) was less pronounced or absent. Campylobacter jejuni counts in excreta samples were significantly lower in chickens fed coated MCFA than in those fed non-coated MCFA. No effect of MCFA on feed intake or growth of chickens was observed. In conclusion, (i) MCFA are active against C. jejuni and (ii) the encapsulation enhanced the efficacy of the acids. These results allow the recommendation of using MCFA as feed additives in chickens, preferably 2-3 days before slaughter.

Effects of capric acid on rumen methanogenesis and biohydrogenation of linoleic and α-linolenic acid.

Capric acid (C10:0), a medium chain fatty acid, was evaluated for its anti-methanogenic activity and its potential to modify the rumen biohydrogenation of linoleic (C18:2n-6) and α-linolenic acids (C18:3n-3). A standard dairy concentrate (0.5 g), supplemented with sunflower oil (10 mg) and linseed oil (10 mg) and increasing doses of capric acid (0, 10, 20 and 30 mg), was incubated with mixed rumen contents and buffer (1 : 4 v/v) for 24 h. The methane inhibitory effect of capric acid was more pronounced at the highest (30 mg) dose compared to the medium (20 mg) (-85% v. -34%), whereas the lower dose (10 mg) did not reduce rumen methanogenesis. A 23% decrease in total short-chain fatty acid (SCFA) production was observed, accompanied by shifts towards increased butyrate at 20 mg and increased propionate at 30 mg of capric acid (P < 0.001). Capric acid linearly decreased the extent of biohydrogenation of C18:2n-6 and C18:3n-3, by up to 60% and 86%, respectively. This reduction was partially due to a lower extent of lipolysis when capric acid was supplemented. Capric acid at 20 and 30 mg completely inhibited the production of C18:0 (P < 0.001), resulting in an accumulation of biohydrogenation intermediates, mainly C18:1t10 + t11 and C18:2t11c15. In contrast to effects on rumen fermentation (methane production and proportions of SCFA), 30 mg of capric acid did not induce major changes in rumen biohydrogenation as compared to the medium (20 mg) dose. This study revealed the dual action of capric acid, being inhibitory to both methane production and biohydrogenation of C18:2n-6 and C18:3n-3.

[Conservative versus operative treatment after ACL-rupture: influence on the muscle strength capability of the lower extremity]. / Konservative vs. operative Behandlungsmethode nach einer ACL-Ruptur: Einfluss auf die muskulären Kraftfähigkeiten der unteren Extremität.

PURPOSE: In this study two groups of ACL-rupture patients having had a conservative or an operative treatment and a similar rehabilitation were compared regarding their muscle strength capabilities, and the clinical outcome. METHODS: Thirty-three patients (mean age 31 years) were selected according to the Lysholm-scores. Twelve patients were conservatively treated (Group I) and were examined between six and 16 months post trauma. Group II consisted of 21 operatively treated patients which were examined between 6 and 16 months post surgery. All patients underwent a clinical exam following the OAK evaluation form and were tested on a Cybex 6000 isokinetic machine. The subjects had to perform concentric contractions of the extensor and flexor muscles of the knee, hip and ankle at 60 and 120 degrees /s. In addition the knee musculature was isometrically tested at knee angles of 0 and 45 degrees . RESULTS: The clinical examination revealed significant (P < 0.05) differences between groups. The operatively treated patients scored better at the tests for ligamentous stability, whereas the testing of the muscular capabilities revealed significant differences (P < 0.05) favouring the conservatively treated patients in the isokinetic measures, (maximal concentric torque M (max,con)) of the knee extensors, knee flexors, and ankle plantarflexors. CONCLUSION: Whereas the clinical examination only revealed the ligamentous stability to be better results in the operatively treated patients, the conservatively treated patients showed better results in the isokinetik strength measures of the knee extensors, knee flexors, and ankle plantarflexors. The better muscular profiles found for the conservatively treated patients suggest that a better regeneration of the corresponding muscular capabilities after an ACL rupture is possible, provided a specific and controlled rehabilitation program is performed. This seems to be more difficult in operatively treated patients even six to 16 months after the surgical intervention.

Pediocin PD-1, a bactericidal antimicrobial peptide from Pediococcus damnosus NCFB 1832.

Pediocin PD-1, produced by Pediococcus damnosus NCFB 1832, is inhibitory to several food spoilage bacteria and food-borne pathogens. However, pediocin PD-1 is not active against other Pediococcus spp. and differs in this respect to other pediocins produced by Pediococcus acidilactici and Pediococcus pentosaceus. Production of pediocin PD-1 starts during early growth and reaches-a plateau at the end of exponential growth. Pediocin PD-1 was partially purified and its size was determined by tricine-SDS-PAGE as approximately 3.5 kDa. The isoelectric point (pI) of pediocin PD-1 is approximately 3.5, as determined with the Rotofor electrofocusing cell (BioRad). Pediocin PD-1 is heat-resistant (10 min at 121 degrees C) and remains active after 30 min of incubation at pH 2-10. Pediocin PD-1 is resistant to treatment with pepsin, papain, alpha-chemotrypsin and trypsin, but not Proteinase K. Pediocin PD-1 is bactericidal against sensitive cells of Oenococcus oeni (previously Leuconostoc oenos).